n-cyclohexylbenzothiazole-2-sulfenamide-brief profile

  • n-cyclohexylbenzothiazole-2-sulfenamide - brief profile - echa

    N-cyclohexylbenzothiazole-2-sulfenamide - Brief Profile - ECHA

    The Brief Profile summarises the non-confidential data on substances as it is held in the databases of the European Chemical Agency (ECHA), including data provided by third parties. The Brief Profile is produced based on data in ECHA’s databases and maintained by the Agency, and therefore the Brief Profile as a dissemination tool falls under

  • n,n-dicyclohexyl-2-benzothiazolesulfenamide | c19h26n2s2

    N,N-Dicyclohexyl-2-benzothiazolesulfenamide | C19H26N2S2

    Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is

  • n-cyclohexylbenzothiazole-2-sulfenamide - substance

    N-cyclohexylbenzothiazole-2-sulfenamide - Substance

    Substance identity Substance identity. The ‘Substance identity’ section is calculated from substance identification information from all ECHA databases. The substance identifiers displayed in the InfoCard are the best available substance name, EC number, CAS number and/or the molecular and structural formulas.

  • n-cyclohexylacetamide | c8h15no

    N-Cyclohexylacetamide | C8H15NO

    Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is

  • n-cyclohexylbenzothiazole-2-sulfenamide - registration

    N-cyclohexylbenzothiazole-2-sulfenamide - Registration

    A read-across is carried out from MBT to CBS, as the primary metabolite of CBS. The Maximum Acceptable Toxicant Concentration (MATC) in an early-life stage test on rainbow trout was determined to be 0.041 - 0.078 mg/l within 89 days for MBT.

  • n-cyclohexylbenzothiazole-2-sulfenamide - registration

    N-cyclohexylbenzothiazole-2-sulfenamide - Registration

    Applicant's summary and conclusion Interpretation of results: GHS criteria not met Conclusions: LD50 > 7940 mg/kg bw. Executive summary: The acute dermal toxicity of the test substance CBS was evaluated with New Zealand Albino rabbits in a limited documented study.

  • n-cyclohexylbenzothiazole-2-sulfenamide - brief profile - echa

    N-cyclohexylbenzothiazole-2-sulfenamide - Brief Profile - ECHA

    The Brief Profile summarises the non-confidential data on substances as it is held in the databases of the European Chemical Agency (ECHA), including data provided by third parties. The Brief Profile is produced based on data in ECHA’s databases and maintained by the Agency, and therefore the Brief Profile as a dissemination tool falls under